Published in

Nature Research, Nature Medicine, 10(27), p. 1850-1850, 2021

DOI: 10.1038/s41591-021-01569-2

Links

Tools

Export citation

Search in Google Scholar

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Journal article published in 2021 by Evdoxia Kyriazopoulou ORCID, Garyfallia Poulakou, Haralampos Milionis, Simeon Metallidis, Georgios Adamis, Konstantinos Tsiakos ORCID, Archontoula Fragkou, Aggeliki Rapti, Christina Damoulari, Massimo Fantoni ORCID, Ioannis Kalomenidis ORCID, Georgios Chrysos, Andrea Angheben ORCID, Ilias Kainis, Zoi Alexiou and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO